Capital Cell
European equity crowdfunding platform for biotech projects. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$3—4m (Dealroom.co estimates Jan 2024.)
Company register number B65998288
Vilassar de Mar Catalonia (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€125k | Seed | ||
* | €650k | Seed | |
* | N/A | Debt | |
Total Funding | $853k |
Related Content
Recent News about Capital Cell
EditMore about Capital Cell
EditCapital Cell is the first pan-European crowdinvesting platform for biotech & Life Sciences companies. Mixing VC, business angels, accredited investors and the power of the Crowd, we are building a global meeting point for companies and researchers working, fostering and financing tomorrow’s medical science. In this health & biotech marketplace, global investors of any size can invest in non-listed companies via equity-crowdfunding with the most accurate scientific and financial information about every project.